The presentation aims at presenting the three main types Covid-19 vaccines, currently in final phase III clinical development, which would likely be the available products for general public distribution in early or mid 2021, including those to be used in Thailand and nearby countries.
In addition to the vaccine part, the specificities of the SARS-CoV2 virus and Covid-19 illness as well as the unique technical and legal environments around this vaccine development and commercialization will be briefly highlighted.
Modalités d'accès
